HomeACRS • NASDAQ
add
Aclaris Therapeutics Inc
Previous close
$1.31
Day range
$1.31 - $1.40
Year range
$0.59 - $11.12
Market cap
96.92M USD
Avg Volume
771.69K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 17.57M | 126.62% |
Operating expense | 8.21M | 14.95% |
Net income | -1.49M | 94.60% |
Net profit margin | -8.49 | 97.62% |
Earnings per share | -0.02 | 95.12% |
EBITDA | -23.59M | — |
Effective tax rate | 19.75% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 119.11M | -45.26% |
Total assets | 197.40M | -22.46% |
Total liabilities | 40.23M | -29.40% |
Total equity | 157.18M | — |
Shares outstanding | 70.93M | — |
Price to book | 0.59 | — |
Return on assets | -28.52% | — |
Return on capital | -37.16% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.49M | 94.60% |
Cash from operations | -6.76M | 64.63% |
Cash from investing | 7.55M | 179.42% |
Cash from financing | 49.00K | 32.43% |
Net change in cash | 838.00K | 105.12% |
Free cash flow | 11.25K | 100.09% |
About
Founded
2012
Website
Employees
89